Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 3/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.65 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.65 |
| ▸ | HTR2B | P41595 | 2/20 | 0.65 |
| ▸ | FAAH | O00519 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | MGLL | Q99685 | 1/20 | 0.62 |
| ▸ | POLB | P06746 | 2/20 | 0.62 |
| ▸ | TACR3 | P29371 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1761001 | 0.90 | TACR3 (0.71) | CYP2C9CYP2C19MAPK14HTR2BFAAH | |
| SCHEMBL4576675 | 0.87 | L3MBTL1 (0.64) | CYP2C9CYP2C19MAPK14HTR2BFAAH | |
| SCHEMBL2636547 | 0.86 | MEN1 (0.68) | CYP2C9CYP2C19MAPK14HTR2BFAAH | |
| SCHEMBL4576736 | 0.85 | L3MBTL1 (0.69) | CYP2C9CYP2C19MAPK14HTR2BFAAH | |
| SCHEMBL3026559 | 0.85 | CYP2C9 (0.67) | CYP2C9CYP2C19MAPK14HTR2BFAAH | |
| SCHEMBL1761030 | 0.84 | MEN1 (0.55) | CYP2C9CYP2C19MAPK14MEN1KMT2A | |
| SCHEMBL2243090 | 0.84 | ALDH1A1 (0.64) | CYP2C9CYP2C19MAPK14HTR2BFAAH | |
| SCHEMBL12466880 | 0.83 | MEN1 (0.64) | CYP2C9CYP2C19MAPK14HTR2BFAAH | |
| SCHEMBL14252818 | 0.83 | MEN1 (0.64) | CYP2C9CYP2C19MAPK14HTR2BFAAH | |
| SCHEMBL8815358 | 0.83 | MEN1 (0.64) | CYP2C9CYP2C19MAPK14HTR2BFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114401969-A | Heterocyclic compounds | 豪夫迈·罗氏有限公司 | 2022-04-26 | — | — | CN | disclosed |
| US-6335324-B1 | TREATING ASTHMA OR ALLERGIC RHINITIS | BRISTOL-MYERS SQUIBB CO. | 2002-01-01 | — | — | US | disclosed |
| EP-1089973-A4 | AMIDINO AND GUANIDINO AZETIDINONE TRYPTASE INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2001-12-12 | — | — | EP | disclosed |
| EP-1089973-A1 | AMIDINO AND GUANIDINO AZETIDINONE TRYPTASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2001-04-11 | — | — | EP | disclosed |
| WO-1999067215-A1 | AMIDINO AND GUANIDINO AZETIDINONE TRYPTASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-12-29 | — | — | WO | disclosed |
| US-4136180-A | HYPOLIPIDEMIC SUBSTITUTED STYRENESULFONYLUREAS | PFIZER INC. (US) | 1979-01-23 | — | — | US | disclosed |
| US-4062960-A | Hypolipidemic alkenesulfonamides | PFIZER INC. (US) | 1977-12-13 | — | — | US | disclosed |
| US-3983107-A | ARTERIOSCLEROSIS | PFIZER INC. (US) | 1976-09-28 | — | — | US | disclosed |